Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance Through p53 Acetylation
Huan Li,Chao Song,Yang Zhang,Guohao Liu,Hailong Mi,Yachao Li,Zhiye Chen,Xiaoyu Ma,Po Zhang,Lidong Cheng,Peng Peng,Hongtao Zhu,Zirong Chen,Minhai Dong,Sui Chen,Hao Meng,QunGen Xiao,Honglian Li,Qiulian Wu,Baofeng Wang,Suojun Zhang,Kai Shu,Feng Wan,Dongsheng Guo,Wenchao Zhou,Lin Zhou,Feng Mao,Jeremy N. Rich,Xingjiang Yu
DOI: https://doi.org/10.1002/advs.202305620
IF: 15.1
2023-12-14
Advanced Science
Abstract:Here, it is found that TAGLN, which is preferentially expressed in GSC, supports the hypoxic response of GSC by binding to HIF1α to form a complex. Mechanistically, TAGLN stabilizes HDAC2 to deacetylate p53 and maintains GSC self‐renewal under hypoxia. Inhibition of TAGLN/HDAC2‐p53 cell cycle axis by sodium valproate combined with natural borneol prolongs the survival of GBM experimental animal models. Glioblastoma (GBM) is a lethal cancer characterized by hypervascularity and necrosis associated with hypoxia. Here, it is found that hypoxia preferentially induces the actin‐binding protein, Transgelin (TAGLN), in GBM stem cells (GSCs). Mechanistically, TAGLN regulates HIF1α transcription and stabilizes HDAC2 to deacetylate p53 and maintain GSC self‐renewal. To translate these findings into preclinical therapeutic paradigm, it is found that sodium valproate (VPA) is a specific inhibitor of TAGLN/HDAC2 function, with augmented efficacy when combined with natural borneol (NB) in vivo. Thus, TAGLN promotes cancer stem cell survival in hypoxia and informs a novel therapeutic paradigm.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry